# ADME Study in Healthy Male Subjects With TA-8995

> **NCT02408055** · PHASE1 · COMPLETED · sponsor: **Xention Ltd** · enrollment: 6 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** TA-8995

## Key facts

- **NCT ID:** NCT02408055
- **Lead sponsor:** Xention Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2016-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408055, "ADME Study in Healthy Male Subjects With TA-8995". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02408055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*